Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a type of cancer called non-Hodgkin's lymphoma in the brain, confirmed through a brain biopsy.
- People whose MRI or CT brain scan shows a specific pattern of abnormal lesions that appear in a way consistent with primary CNS lymphoma (lymphoma originating in the brain or spinal cord).
- People whose pre-treatment tests — including a bone marrow sample and CT scans of the chest, abdomen, and pelvis — show no spread of lymphoma to other parts of the body, and whose bone marrow is functioning well enough to participate.
- People who have tested negative for HIV-1.
- People who are capable of having children and who agree to use an acceptable form of birth control during treatment and for six months after treatment ends.
Who may not be able to join:
- People with a past history of a major psychiatric (mental health) condition.
- People who have previously had radiation treatment to the head, for any reason.
- People who currently have another active cancer, except for a specific type of non-aggressive skin cancer (basal cell carcinoma) or very early-stage cervical cancer that has not spread.
- People who already have a weakened immune system for medical reasons, such as those who have received a kidney transplant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +886-33281200
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary endpoint is the change in patients' capability of information processing, as determined by the assessment (the Paced Auditory Serial Addition Test-Revised) from baseline up to 30 months after completing all courses of chemoradiation.; The primary endpoint is delayed recall, as determined by the change/decline in verbal memory (Word Sequence Learning Test) from baseline up to 30 months after completing all courses of chemoradiation.; The primary endpoint is the change of executive function, as determined by three different domains assessments from baseline up to 30 months after comp...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.